Lineage Cell Therapeutics
LCTX
LCTX
127 hedge funds and large institutions have $49.7M invested in Lineage Cell Therapeutics in 2025 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 37 increasing their positions, 22 reducing their positions, and 16 closing their positions.
Holders
127
Holders Change
+1
Holders Change %
+0.79%
% of All Funds
1.73%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
19
Increased
37
Reduced
22
Closed
16
Calls
$133K
Puts
$1K
Net Calls
+$132K
Net Calls Change
+$95K
Top Buyers
1 |
BC
1
Broadwood Capital
New York
|
$22.4M |
2 |
2
Comerica Bank
Dallas,
Texas
|
$1.35M |
3 |
3
BlackRock
New York
|
$5.17M |
4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$2.03M |
5 |
GCP
5
GSA Capital Partners
London,
United Kingdom
|
$423K |